Intermountain Primary Children's Hospital is a nationally ranked pediatric acute care children's teaching hospital located in Salt Lake City, Utah. The hospital has 289 pediatric beds and is affiliated with the University of Utah School of Medicine.

There are 289 beds in Primary Children's Hospital.

During the past decade, Primary Children's Hospital conducted 203 clinical trials. In the 10-year time frame, 203 clinical trials started and 152 clinical trials were completed, i.e. on average, 74.9% percent of trials that started reached the finish line to date. In the past 5 years, 86 clinical trials started and 80 clinical trials were completed. i.e. 93% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Primary Children's Hospital" #1 sponsor was "Children's Oncology Group" with 121 trials, followed by "National Cancer Institute (NCI)" with 61 trials sponsored, "University of Utah" with 54 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 13 trials sponsored and "Pfizer" with 13 trials sponsored. Other sponsors include 156 different institutions and companies that sponsored additional 99 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Primary Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 124 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 21 trials as a collaborator, "Primary Children's Hospital" with 12 trials as a collaborator, "Children's Oncology Group" with 11 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 10 trials as a collaborator. Other collaborators include 327 different institutions and companies that were collaborators in the rest 170 trials.

According to Clinical.Site data, the most researched conditions in "Primary Children's Hospital" are "Recurrent Neuroblastoma" (21 trials), "Cystic Fibrosis" (17 trials), "Recurrent Osteosarcoma" (16 trials), "Neuroblastoma" (15 trials) and "Refractory Neuroblastoma" (15 trials). Many other conditions were trialed in "Primary Children's Hospital" in a lesser frequency.

Most popular intervention types in "Primary Children's Hospital" are "Drug" (271 trials), "Other" (129 trials), "Procedure" (86 trials), "Biological" (85 trials) and "Radiation" (57 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (59 trials), "Cyclophosphamide" (50 trials), "Vincristine Sulfate" (39 trials), "Cytarabine" (33 trials) and "Etoposide" (32 trials). Other intervention names were less common.

The vast majority of trials in "Primary Children's Hospital" are 415 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are 175 active trials in "Primary Children's Hospital". 2 are not yet recruiting, 85 are recruiting, 85 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 205 completed trials in Primary Children's Hospital, 4 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Primary Children's Hospital, 46 "Phase 1" clinical trials were conducted, 132 "Phase 2" clinical trials and 140 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 37 trials that are defined as “Not Applicable".